VEGFA and neoplasm: The [89Zr]Zr-bevacizumab uptake was visualized in 96.1% of primary lesions with a significant correlation between [89Zr]Zr-bevacizumab tumor uptake and VEGF-levels as measured by ELISA (enzyme-linked immunosorbent assay).